| scholarly article | Q13442814 |
| P50 | author | Jeanne Loring | Q24759332 |
| P2093 | author name string | Manfred Westphal | |
| Katrin Lamszus | |||
| Nils Ole Schmidt | |||
| Franz-Josef Müller | |||
| Frank Zeigler | |||
| Katharina Hansen | |||
| Markus Messing | |||
| P2860 | cites work | A microtransplantation approach for cell suspension grafting in the rat parkinson model: A detailed account of the methodology | Q59574604 |
| Transected spinal cords grafted with in situ self-assembled collagen matrices | Q68564833 | ||
| Collagen fibrillogenesis in a three-dimensional fibroblast cell culture system | Q70488065 | ||
| Primary neural precursor cell expansion, differentiation and cytosolic Ca(2+) response in three-dimensional collagen gel | Q73098843 | ||
| Regeneration of intraoral defects after tumor resection with a bioengineered human dermal replacement (Dermagraft) | Q77744474 | ||
| Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas | Q80829209 | ||
| Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells | Q81415175 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Tissue engineering | Q29617288 | ||
| The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue | Q34154476 | ||
| Strategies for the augmentation of grafted dopamine neuron survival | Q35109477 | ||
| Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury | Q35587085 | ||
| Targeting of melanoma brain metastases using engineered neural stem/progenitor cells | Q35800609 | ||
| Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas | Q35827956 | ||
| A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma | Q35894943 | ||
| Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach. | Q36048041 | ||
| Gene therapy: can neural stem cells deliver? | Q36350210 | ||
| CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure | Q36499527 | ||
| Collagen fillers | Q36511386 | ||
| Getting the right stuff: controlling neural stem cell state and fate in vivo and in vitro with biomaterials | Q36702758 | ||
| Injectable collagens: lost but not forgotten--a review of products, indications, and injection techniques | Q37036168 | ||
| Stem and progenitor cell-mediated tumor selective gene therapy | Q37120161 | ||
| Cellular repair of CNS disorders: an immunological perspective. | Q37218561 | ||
| Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. | Q38922636 | ||
| The extracellular matrix as a cell survival factor | Q40241699 | ||
| Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. | Q40394957 | ||
| Implantable Biohybrid Artificial Organs | Q40427311 | ||
| Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model. | Q40587263 | ||
| Characterization, barrier function, and drug metabolism of an in vitro skin model | Q42509550 | ||
| The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma | Q42809291 | ||
| Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression | Q42835214 | ||
| A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. | Q43757230 | ||
| AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study | Q45127753 | ||
| A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. | Q45739549 | ||
| Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience | Q46476922 | ||
| Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias | Q46634561 | ||
| Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. | Q48573032 | ||
| Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. | Q48789795 | ||
| Establishment of three-dimensional culture of neural stem/progenitor cells in collagen Type-1 Gel. | Q50667894 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | extracellular matrix | Q193825 |
| P304 | page(s) | 645-654 | |
| P577 | publication date | 2010-02-14 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | A 3-dimensional extracellular matrix as a delivery system for the transplantation of glioma-targeting neural stem/progenitor cells | |
| P478 | volume | 12 |
| Q89936443 | Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma |
| Q38944271 | Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy. |
| Q46295328 | Human Neural Stem Cell Biodistribution and Predicted Tumor Coverage by a Diffusible Therapeutic in a Mouse Glioma Model |
| Q47975817 | Implantable systems for drug delivery to the brain |
| Q36861449 | Intranasal delivery of neural stem/progenitor cells: a noninvasive passage to target intracerebral glioma |
| Q39021847 | Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution. |
| Q38245163 | Stem cell-based therapies for cancer treatment: separating hope from hype |
| Q47142453 | Stem cells in cancer therapy: opportunities and challenges |
| Q37365857 | Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells. |
Search more.